Lyophilized Peptide Bivalirudin Trifluoroacetate with High Quality and Reasonable Price

Appearence: White Powder
Supply Ability: 500000kg/Year
Certificate: GMP
Packing: Plastic Tube
Shelf Life: 2years
Storage Way: Dry and Cool Place
Trademark: FILTER
Transport Package: Plastic Tube / Vial
Specification: 2mg/vial, 10vials/box
Origin: Shanghai
HS Code: 3003901000
Appearence: White Powder
Supply Ability: 500000kg/Year
Certificate: GMP
Packing: Plastic Tube
Shelf Life: 2years
Storage Way: Dry and Cool Place
Trademark: FILTER
Transport Package: Plastic Tube / Vial
Specification: 2mg/vial, 10vials/box
Origin: Shanghai
HS Code: 3003901000

 Lyophilized Peptide Bivalirudin Trifluoroacetate  with High Quality and Reasonable Price
Lyophilized Peptide Bivalirudin Trifluoroacetate with High Quality and Reasonable Price
 

Description

Product name: Bivalirudin 
Byname: Bivalirudin Trifluoroacetate 
CAS NO: 128270-60-0 
Molecular Formula: C98H138N24O33

 Introduction

Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin.It inhibits both circulating and clot-bound thrombin,while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life.It does not bind to plasma proteins (other than thrombin) or to red blood cells. Therefore it has a predictable antithrombotic response. There is no risk for Heparin Induced Thrombocytopenia/Heparin Induced Thrombosis-Thrombocytopenia Syndrome (HIT/HITTS).It does not require a binding cofactor such as antithrombin and does not activate platelets.These characteristics make bivalirudin an ideal alternative to heparin.

Function          

Bivalirudin is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA). Bivalirudin with provisional use of glycoprotein IIb/IIIa inhibitor (GPI) is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI). Bivalirudin is indicated for patients with, or at risk of HIT/HITTS undergoing PCI. Bivalirudin is intended for use with aspirin and has been studied only in patients receiving concomitant aspirin. 

COA                                                       

Product Name

Bivalirudin Trifluoroacetate 

Cas No.

128270-60-0

Molecular Formula

C98H138N24O33

Molecular Weight

2180.33

Purity (HPLC)

99.0%min.

Appearance 

White powder

Single Impurity (HPLC) 

0.5%max

Amino Acid Composition 

±10% of theoretical

Peptide Content (N%)

≥80.0%

Water Content (Karl Fischer) 

≤8.0%

Acetate Content (HPIC)

≤12.0%

MS (ESI)

Consistent

Mass Balance 

95.0~105.0%


Lyophilized Peptide Bivalirudin Trifluoroacetate with High Quality and Reasonable Price


Contact us:
Maria
 
 
 
 

 Lyophilized Peptide Bivalirudin Trifluoroacetate  with High Quality and Reasonable Price
Lyophilized Peptide Bivalirudin Trifluoroacetate with High Quality and Reasonable Price
 

Description

Product name: Bivalirudin 
Byname: Bivalirudin Trifluoroacetate 
CAS NO: 128270-60-0 
Molecular Formula: C98H138N24O33

 Introduction

Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin.It inhibits both circulating and clot-bound thrombin,while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life.It does not bind to plasma proteins (other than thrombin) or to red blood cells. Therefore it has a predictable antithrombotic response. There is no risk for Heparin Induced Thrombocytopenia/Heparin Induced Thrombosis-Thrombocytopenia Syndrome (HIT/HITTS).It does not require a binding cofactor such as antithrombin and does not activate platelets.These characteristics make bivalirudin an ideal alternative to heparin.

Function          

Bivalirudin is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA). Bivalirudin with provisional use of glycoprotein IIb/IIIa inhibitor (GPI) is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI). Bivalirudin is indicated for patients with, or at risk of HIT/HITTS undergoing PCI. Bivalirudin is intended for use with aspirin and has been studied only in patients receiving concomitant aspirin. 

COA                                                       

Product Name

Bivalirudin Trifluoroacetate 

Cas No.

128270-60-0

Molecular Formula

C98H138N24O33

Molecular Weight

2180.33

Purity (HPLC)

99.0%min.

Appearance 

White powder

Single Impurity (HPLC) 

0.5%max

Amino Acid Composition 

±10% of theoretical

Peptide Content (N%)

≥80.0%

Water Content (Karl Fischer) 

≤8.0%

Acetate Content (HPIC)

≤12.0%

MS (ESI)

Consistent

Mass Balance 

95.0~105.0%


Lyophilized Peptide Bivalirudin Trifluoroacetate with High Quality and Reasonable Price


Contact us:
Maria
 
 
 
 

Supports & Braces

With the improvement of people's living standards, people pay more and more attention to the importance of physical health. More and more people will use their spare time to exercise, run, ride, climb mountains and so on.
But then comes the safety of sports. A little too much force or improper operation will cause injury. It was originally for the sake of health, but it was only a few days after exercise, which is a bit more than worth the loss.
Nowadays, more and more people begin to pay attention to their health. Running has become the first choice of most people because of its relatively low technical threshold. With the rise of running craze, a variety of equipment has also quietly jumped into the sight of runners, from professional running shoes, sweat-absorbing clothes and pants, wearable electronic devices, and shin and patella band and other protective devices. Running is often prone to sprains, falls and other accidents. Choosing a knee pad that can protect the body is very important.
For runners, there are also several common injuries, such as knee pain, iliotibial tract syndrome, foot blister, sprain wait. How did you solve or avoid the pain problem?
Knee pads and waist support are very good for sports injuries&protective equipment


TRUTECH CO., LTD. is an enterprise specializing in the research, development, production and sales of professional OTC products.The main products include shower chairs, armrests, toilet racks and toilet armrests, bedside armrests, elderly chairs and sofas, crutches and walking aids, knee pads, waist supports and other equipment.

Supports & Braces,Back Brace,Carpal Tunnel Brace,Ankle Support Brace

TRUTECH CO., LTD. , https://www.trutechealth.com